TG 100572
CAS: 867334-05-2
Rif. 3D-SJB33405
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
TG 100572 is a growth factor that is being developed for the treatment of neovascular eye disorders, such as age-related macular degeneration (AMD) and choroidal neovascularization. This drug has been shown to inhibit the growth of cancer cells by blocking the receptor for vascular endothelial growth factor (VEGF). TG 100572 also inhibits angiogenesis, which is the formation of new blood vessels from pre-existing ones. It does this by inhibiting basic fibroblast growth factor (bFGF)-induced proliferation and migration of endothelial cells. TG 100572 has also been shown to inhibit inflammatory cells, such as monocytes and macrophages, which are involved in many diseases. The phenotype of TG 100572 is not yet known.
Proprietà chimiche
Richiesta tecnica su: 3D-SJB33405 TG 100572
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
